Broker Center sponsored links

Hi-Tech Pharmacal gets tentative nod for nail fungus treatment

Tue Apr 17, 2007 8:17am EDT
 
Email | Print | | Reprints | Single Page
[-] Text [+]

April 17 (Reuters) - Hi-Tech Pharmacal Co. Inc. (HITK.O: Quote, Profile, Research, Stock Buzz) said the U.S. Food and Drug Administration tentatively approved its Ciclopirox, which is the generic equivalent of Dermik Laboratories' Penlac nail fungus treatment.

Final approval is expected upon expiration of Penlac's patent on Sept. 18, the company said in a statement. (Reporting by Anant Vijay Kala in Bangalore)

 

Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.

Have a correction to this article? Email the editors

Featured Broker sponsored link

Editor's Choice

  • Pictures
  • Video
  • Articles
Photo

A selection of our best photos from the past 24 hours.  View Slideshow 

Most Popular on Reuters

  • Articles
  • Video
  • Recommended